Clinical Trial Update: Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immunonutrition benefits in head and neck cancer patients receiving chemoradiation, focusing on oral mucositis outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Snippet

Sponsor: Prince of Songkla University | Conditions: Oral Mucositis | Phase 2 | Status: COMPLETED